Aug 5 |
Theravance Biopharma (TBPH) Reports Q2 Loss, Lags Revenue Estimates
|
Aug 5 |
Theravance Biopharma GAAP EPS of -$0.34 misses by $0.13, revenue of $14.25M
|
Aug 4 |
Theravance Biopharma Q2 2024 Earnings Preview
|
Jul 24 |
Theravance Biopharma, Inc. (NASDAQ:TBPH): When Will It Breakeven?
|
Jul 22 |
Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024
|
Jul 15 |
Best Momentum Stocks to Buy for July 15th
|
Jun 27 |
Investors in Theravance Biopharma (NASDAQ:TBPH) have unfortunately lost 52% over the last five years
|
Jun 26 |
Here's Why You May Invest in Theravance (TBPH) Stock Now
|
Jun 21 |
Wall Street Analysts Predict a 90.53% Upside in Theravance Bio (TBPH): Here's What You Should Know
|
Jun 12 |
Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?
|